select search filters
briefings
roundups & rapid reactions
Fiona fox's blog
We asked some scientists with expertise in hantavirus and/or public health responses to viruses and infectious diseases to sit on this panel to answer journalists’ questions on the science.
This briefing also included information about what the ISARIC collaboration (a collaboration of UK investigators from the Universities of Liverpool, Edinburgh, Glasgow, and Oxford) is currently doing in the UK to research the disease.
Some info about ISARIC: ISARIC is a global federation of investigator-led clinical research networks: a network of networks. ISARIC has over 70 member networks, and many partners. ISARIC conducts clinical research to improve patients’ care and facilitate a globally coordinated and agile research response to infectious disease threats. For over a decade, ISARIC has been generating clinically meaningful research evidence for diseases including COVID-19, dengue, Ebola, Lassa fever, Nipah, mpox and bubonic plague.
Speakers included:
Prof Lance Turtle, Chair in Immunity and Infectious Diseases, University of Liverpool
Prof Sir Andrew Pollard FRCPCH FMedSci FRS, Ashall Professor of Infection and Immunity, Pandemic Sciences Institute, and Director of the Oxford Vaccine Group, University of Oxford
Prof Boris Klempa, International Society for Hantaviruses, and Institute of Virology, Slovak Academy of Sciences
Prof Nicole Tischler, President of the International Society for Hantaviruses; and Principal Investigator in the Molecular Virology Lab, Ciencia & Vida and Universidad San Sebastián
Please note that this is an on-record briefing for the specialist journalists on our press lists – but it isn’t a public event and we’re not allowing live-streaming. Please do not share the registration details publicly, and please check with us before forwarding to colleagues not on our lists.
Speakers will include:
Prof Lance Turtle, Chair in Immunity and Infectious Diseases, University of Liverpool
Prof Sir Andrew Pollard FRCPCH FMedSci FRS, Ashall Professor of Infection and Immunity, Pandemic Sciences Institute, and Director of the Oxford Vaccine Group, University of Oxford
Prof Boris Klempa, International Society for Hantaviruses, and Institute of Virology, Slovak Academy of Sciences
Prof Nicole Tischler, President of the International Society for Hantaviruses; and Principal Investigator in the Molecular Virology Lab, Ciencia & Vida and Universidad San Sebastián